An 82‑year‑old female nursing‑home resident presents with a six‑month decline in mood and activity, a three‑week history of confusion and nighttime agitation, 20‑lb weight loss, decreased appetite, fatigue, mild bilateral lower‑extremity edema, MMSE 28/30 with short‑term memory impairment, normal electrolytes, renal function, glucose, liver enzymes, and head CT showing only mild age‑related atrophy. She is taking lisinopril, diltiazem, metformin, pravastatin, fluoxetine, vitamin D, low‑dose aspirin, acetaminophen, and tramadol. Past medical history includes hypertension, type 2 diabetes, hyperlipidemia, depression, obesity, osteoarthritis, venous stasis dermatitis, prior uterine cancer, recent urosepsis, and chronic constipation. What is the most likely diagnosis and what immediate management steps should be taken?

Delirium Superimposed on Depression and Underlying Cognitive Impairment

This patient has delirium superimposed on worsening depression, with probable underlying cognitive impairment, and requires immediate delirium workup, medication review with deprescribing of high-risk agents (particularly tramadol), and optimization of her antidepressant therapy.

Primary Diagnosis: Delirium

The acute three-week history of confusion with nighttime agitation (sundowning), fluctuating course, and acute functional decline in a patient with pre-existing risk factors definitively indicates delirium 1. The 2025 Alzheimer's Association guidelines emphasize that delirium is a medical emergency requiring urgent evaluation, as it accelerates cognitive decline, increases mortality, and can cause irreversible losses when untreated 1.

Key Diagnostic Features Present:

• Acute onset (3 weeks) with fluctuating course (worse at night)
• Inattention (MMSE shows impaired immediate recall: 1/3 after distraction)
• Altered cognition (confusion, disorientation episodes)
• Sleep-wake disturbance (daytime somnolence, nighttime agitation)
• Behavioral changes (agitation, withdrawal from activities)

The MMSE of 28/30 does not exclude delirium—this score can be misleadingly preserved in hypoactive delirium, which this patient demonstrates 1.

Secondary Diagnosis: Inadequately Treated Depression

The six-month progressive decline in mood, anhedonia, social withdrawal, weight loss (20 lbs), appetite changes, and fatigue indicate worsening major depression despite fluoxetine 40mg daily 2. Guidelines specify that older adults with diabetes who present with new-onset or recurrent depression should be treated or have therapy modified within 2 weeks, with reassessment at 6 weeks 2. This patient has had no documented reassessment or dose adjustment despite clear treatment failure.

Tertiary Concern: Underlying Cognitive Impairment

While the head CT shows only age-appropriate atrophy, the MMSE deficits (inability to spell WORLD backward, poor delayed recall), combined with recent functional decline requiring assistance with dressing, suggest mild cognitive impairment or early dementia 2, 3. The 2020 Canadian guidelines emphasize that diabetes increases dementia risk and that cognitive assessment should occur with any significant decline in self-care 3.

---

Immediate Management Steps

1. Identify and Treat Delirium Precipitants (Priority #1)

Conduct urgent evaluation for reversible causes 1:

Infection workup:

• Urinalysis shows trace protein and 9 WBCs—while not overtly positive, recent urosepsis history makes recurrent UTI a prime suspect
• Obtain urine culture
• Check CBC with differential, blood cultures if febrile
• Chest examination already negative for pneumonia

Metabolic/endocrine causes:

• Thyroid function tests (nodular thyroid on exam; hypothyroidism causes cognitive impairment) 2
• Vitamin B12 level (recommended for all older adults with cognitive impairment) 2
• Electrolytes are normal, but check calcium (already 8.9, low-normal—consider ionized calcium)
• Consider TSH given nodular thyroid on examination

Constipation:

• Patient reports constipation with hypoactive bowel sounds and vague LLQ mass—fecal impaction is a common delirium precipitant in nursing homes 4
• Perform rectal examination
• Abdominal imaging if impaction suspected

Medication-induced delirium:

• See detailed medication review below

2. Comprehensive Medication Review and Deprescribing (Priority #2)

IMMEDIATELY DISCONTINUE TRAMADOL 5, 6, 7:

• Tramadol carries extremely high delirium risk in older adults 5, 7
• FDA labeling warns of confusion, altered mental status, and serotonin syndrome risk, especially with SSRIs (fluoxetine) 7
• The 2021 Mayo Clinic polypharmacy guidelines identify tramadol as a high-risk medication requiring deprescribing in older adults 6
• Replace with scheduled acetaminophen 1000mg TID (already taking PRN; make it scheduled for OA pain) 5

Evaluate fluoxetine adequacy:

• Six months of worsening depression on fluoxetine 40mg indicates treatment failure 2
• However, do NOT abruptly discontinue during acute delirium
• Once delirium resolves, consider switching to an antidepressant with better evidence in older adults with cognitive impairment
• Mirtazapine or venlafaxine may be preferable (avoid tricyclics due to anticholinergic burden) 6

Review other medications for anticholinergic burden:

• Current regimen has minimal anticholinergic load (no diphenhydramine, oxybutynin, or other high-risk agents) 6
• Continue current cardiovascular medications (lisinopril, diltiazem, pravastatin, ASA)
• Metformin is appropriate; glucose control is adequate (109 mg/dL)

3. Non-Pharmacologic Delirium Management (Priority #3)

Implement multicomponent delirium prevention/treatment protocol 4:

Orientation and cognitive stimulation:

• Ensure glasses and hearing aids (bilateral cerumen impaction noted—remove cerumen immediately to restore hearing) 4
• Provide clock, calendar, familiar objects
• Frequent reorientation by staff and daughter
• Cognitive engagement activities during the day

Sleep-wake cycle restoration:

• Minimize nighttime disruptions
• Avoid daytime napping
• Natural light exposure during day
• Quiet environment at night (she watches TV "very loudly"—address hearing impairment first)

Early mobilization:

• Physical therapy for ambulation with walker
• Prevent deconditioning
• Reduce fall risk (already has mobility decline × 3 weeks)

Hydration and nutrition:

• Address decreased appetite and GI complaints
• Specific gravity 1.002 suggests adequate hydration, but monitor
• Nutritional supplementation for 20-lb weight loss

Avoid physical restraints and minimize psychotropic medications unless severe agitation poses safety risk 4.

4. Address Underlying Depression (After Delirium Stabilizes)

Once delirium resolves (typically days to weeks with treatment of precipitants):

• Reassess depression severity with validated tool (PHQ-9 or GDS)
• If fluoxetine remains inadequate after 6 weeks at current dose, consider:
  • Increasing to 60mg daily (if tolerated)
  • Switching to alternative SSRI or SNRI
  • Adding psychotherapy/behavioral activation
• Re-evaluate at 6 weeks per guidelines 2
• Monitor for treatment-emergent suicidal ideation (though no current SI/HI noted)

5. Cognitive Assessment After Delirium Resolution

• Repeat MMSE or use MoCA (more sensitive for MCI) once delirium clears 3
• If cognitive impairment persists, complete workup per guidelines:
  • TSH, B12 already ordered above
  • Consider referral to neurology/geriatrics if atypical features or rapid progression 1
  • Functional assessment with informant (daughter)

---

Critical Pitfalls to Avoid

Do not attribute acute confusion solely to "dementia" or "depression" without ruling out delirium—this delays life-saving treatment 1.

Do not continue tramadol in any older adult with confusion, especially with concurrent SSRI use (serotonin syndrome risk) 5, 6, 7.

Do not start antipsychotics for delirium without first addressing reversible causes and implementing non-pharmacologic interventions 4. If severe agitation requires pharmacologic management, use low-dose haloperidol or quetiapine cautiously and temporarily.

Do not overlook sensory impairments—bilateral cerumen impaction is directly contributing to social withdrawal, loud TV use, and disorientation 4. This is immediately reversible.

Do not miss fecal impaction—the vague LLQ mass, constipation, hypoactive bowel sounds, and new GI complaints ("cafeteria food makes her stomach hurt") strongly suggest this treatable cause 4.

Do not delay treatment of inadequately controlled depression—six months of worsening symptoms without intervention violates guideline-recommended timelines 2.

---

Expected Outcomes with Appropriate Management

With prompt identification and treatment of delirium precipitants, medication optimization, and non-pharmacologic interventions, expect:

• Delirium resolution within days to weeks
• Improved functional status and return to baseline ADLs
• Reduced mortality risk (delirium increases 30-day mortality significantly) 1
• Better depression control with medication adjustment
• Prevention of accelerated cognitive decline that occurs with untreated delirium 1

The combination of recent urosepsis, medication-induced delirium (tramadol), sensory deprivation (cerumen), possible fecal impaction, and undertreated depression creates a perfect storm for delirium in this vulnerable older adult. Aggressive, systematic treatment of each reversible factor is essential to prevent irreversible harm 1, 4.